Howard Lee - 20 May 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
20 May 2021
Transactions value $
-$33,054
Form type
4
Filing time
24 May 2021, 16:45:23 UTC
Next filing
08 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $164,300 +10,000 +7.52% $16.43 142,914 20 May 2021 Direct
transaction AMPH Common Stock Sale -$197,354 -10,000 -7% $19.74 132,914 20 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -10,000 -38.72% $0 15,827 20 May 2021 Common Stock 10,000 $16.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.66 to $19.945 shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.